Advertisement

Topics

Stryker Company Profile

18:24 EST 21st November 2017 | BioPortfolio

At Stryker, we believe results speak louder than words. Since the Company's founding in 1941, that philosophy has made us a leader in the worldwide orthopaedic market and placed us at the forefront of medicine's most promising solutions. Today, we are one of the preeminent medical products and services companies in the world. Our company is one that sets high standards. We focus on the fundamentals and we're relentless in attending to the details. We are passionate about raising the bar - and regularly surpass our own ambitious goals. Our Industry Company History We continually strive to achieve superior clinical results. We push the frontiers of medical research while maintaining uncompromising clinical integrity. We succeed when our customers succeed. We put their interests first in everything we do. We not only give them responsive, timely service, we also help to make them more efficient. Most importantly, we measure our success by our ability to partner with respected medical professionals - to help millions of people, around the world, lead more active and more satisfying lives. At Stryker, we don't just make promises, we deliver results.

Location

2825 Airview Boulevard
Kalamazoo
MI
49002
United States of America

Contact

Phone: 269 385 2600
Fax: 269 385 1062
Email: info@op1.com


News Articles [70 Associated News Articles listed on BioPortfolio]

Stryker elects new director

Mary Brainerd has been elected to the board of directors of Stryker.  -More- 

VEXIM Acquired by Stryker in EUR 183M Deal

Stryker picked up controlling interest in Vexim, a French medical device company that specializes in the minimally invasive treatment of vertebral fractures.

Stryker buys majority stake in Vexim

Stryker Corp. is acquiring a 50.7% stake (4.1mm shares at $23.56 (€20) each, a 29% premium, and warrants at $4.61 each) in public French device maker Vexim SAS.

Stryker, Philips reach partnership on Save Simply program

An agreement was reached by Stryker's Sustainability Solutions division and Philips to provide an option for the division's c -More- 

Stryker Corp. Reveals 11% Increase In Q2 Bottom Line

WASHINGTON (dpa-AFX) - Stryker Corp. (SYK) reported earnings for its second quarter that advanced compared to the same period last year.The company said its bottom line totaled $581 million, or $1...

VEXIM to be Acquired by Stryker Corporation

Acquisition of a controlling stake by Stryker Corporation, followed by the filing of a simplified all-cash tender offer with intention to implement a squeeze-out. Acquisition will help accelerate ...

Stryker's $700M acquisition of Novadaq gains approval from Canadian court

A final order has been issued by the Ontario Superior Court of Justice approving Stryker's acquisition of fluorescence imagin -More- 

Stryker awarded $248.7 million in patent case against Zimmer

(Reuters) - A U.S. judge has increased the amount medical device maker Zimmer Biomet Holdings Inc must pay Stryker Corp for infringing patents on a surgical cleaning wand to $248.7 million following a...

Drugs and Medications [0 Results]

None

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Biomechanical comparison of a novel monocortical and two common bicortical external fixation systems regarding rigidity and dynamic stability.

To biomechanically compare a monocortical single frame external fixator (Orthofix UNYCO) with two bicortical fixator systems (dual frame: Stryker Hoffmann and single frame: Synthes LEF) with respect t...

Subharmonic-Aided Pressure Estimation for Monitoring Interstitial Fluid Pressure in Tumors: Calibration and Treatment with Paclitaxel in Breast Cancer Xenografts.

Interstitial fluid pressure (IFP) in rats with breast cancer xenografts was non-invasively estimated using subharmonic-aided pressure estimation (SHAPE) versus an invasive pressure monitor. Moreover, ...

Patient-Reported Outcomes following Single- and Multiple-Radius Total Knee Replacement: A Randomized, Controlled Trial.

Although single-radius (SR) designs of total knee replacement (TKR) have theoretical benefits, the clinical advantage conferred by such designs is unknown. The aim of this randomized, controlled study...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot

A prospective, randomised controlled trial evaluating Total Knee Replacement with the Stryker Triathlon Primary Total Knee System, compared to Bicompartmental Knee Replacement with Restori...

A Trial of Mechanical Axis vs Kinematic Alignment in Total Knee Replacement

This is a prospective, randomized, longitudinal study of the clinical outcomes of osteoarthritis patients treated by two different alignment philosophies for total knee replacement. In thi...

Fluoroscopic and RSA Evaluation of the Triathlon Total Knee Prosthetic Design

The goal of this study is to compare the fixed bearing (FB) Triathlon knee (Stryker, USA) and the mobile bearing (MB) Triathlon knee (Stryker, USA) and study the effect of implant design o...

Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using Shapematch Cutting Guides:Sub-Study A

This is a prospective, non-randomized, longitudinal study of the clinical outcomes of participants that receive the Stryker Triathlon® Total Knee System for Total Knee Arthroplasty implan...

Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using ShapeMatch® Cutting Guides: Sub-Study B

This is a prospective, non-randomized, longitudinal study of the clinical outcomes of participants that receive the Stryker Triathlon® Total Knee System for Total Knee Arthroplasty implan...

Companies [11 Associated Companies listed on BioPortfolio]

Stryker Orthopaedics

Stryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including...

Stryker Interventional Spine

Stryker Interventional Spine is a business unit of Stryker Corporation, one of the world's leading medical technology companies. Stryker IVS provides an extensive and innovative product offering for v...

Stryker Communications

Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The company pr...

Stryker Corporation

Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient...

Stryker Spine

Stryker is one of the world's leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of ...

More Information about "Stryker" on BioPortfolio

We have published hundreds of Stryker news stories on BioPortfolio along with dozens of Stryker Clinical Trials and PubMed Articles about Stryker for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stryker Companies in our database. You can also find out about relevant Stryker Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record